Yoshihiko Yagi

821 citations

13 papers · 681 indexed · h-index 10

Organic Chemistry top 5%
Virology top 10%
- HIV Research and Treatment 5
Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 6
- Antimicrobial Resistance in Staphylococcus 3
Molecular Medicine
Toxicology
Epidemiology
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Infective Endocarditis Diagnosis and Management 2
Molecular Biology
- DNA Repair Mechanisms 2
Cancer Research
- Carcinogens and Genotoxicity Assessment 2
Public Health, Environmental and Occupational Health
- Streptococcal Infections and Treatments 2

Co-authors: W. Gary Tarpley Carolyn Biles Donna L. Romero Susan M. Poppe Steven Swaney Don B. Clewell Michaël Génin Arthur E. Franke
Cited by: Organic Chemistry Virology Infectious Diseases
Journals: Journal of Molecular Biology (1 paper)Journal of Medicinal Chemistry (5 papers)Antimicrobial Agents and Chemotherapy (2 papers)
Partner nations: United States Japan Brazil

In The Last Decade

Yoshihiko Yagi

13 papers receiving 612 citations

Peers

Countries citing papers authored by Yoshihiko Yagi

Since Specialization

Citations

This map shows the geographic impact of Yoshihiko Yagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshihiko Yagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshihiko Yagi more than expected).

Fields of papers citing papers by Yoshihiko Yagi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshihiko Yagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshihiko Yagi. The network helps show where Yoshihiko Yagi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yoshihiko Yagi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yoshihiko Yagi Line = papers co-authored together Yoshihiko Yagi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work
1	Near-full-length REV3L appears to be a scarce maternal factor in Xenopus laevis eggs that changes qualitatively in early embryonic development DNA repair ·Daichi Ogawara,Taketo Muroya,K. Yamauchi,Takaaki Iwamoto,Yoshihiko Yagi,Yoshihiro Yamashita,S Waga,Masahiro Akiyama,Hisaji Maki	2009	5
2	DNA polymerases η and κ are responsible for error-free translesion DNA synthesis activity over a cis–syn thymine dimer in Xenopus laevis oocyte extracts DNA repair ·Yoshihiko Yagi,Daichi Ogawara,Shigenori Iwai,Fumio Hanaoka,Masahiro Akiyama,Hisaji Maki	2005	26
3	Structure–activity relationships of acyloxyamidine cytomegalovirus DNA polymerase inhibitors Bioorganic & Medicinal Chemistry ·John A. Tucker,Terrance L. Clayton,Connie G. Chidester,Martin W. Schulz,Leigh E. Harrington,Steven J. Conrad,Yoshihiko Yagi,Nancee L. Oien,David M. Yurek,M. S. KUO	2000	21
4	Naphthalene carboxamides as inhibitors of human cytomegalovirus DNA polymerase Bioorganic & Medicinal Chemistry Letters ·Valerie Vaillancourt,Michele M. Cudahy,Sandra A Staley,Roger J. Brideau,Steven J. Conrad,Mary L. Knechtel,Nancee L. Oien,Janet L. Wieber,Yoshihiko Yagi,Michael W. Wathen	2000	23
5	Novel 1,5-Diphenylpyrazole Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors with Enhanced Activity versus the Delavirdine-Resistant P236L Mutant: Lead Identification and SAR of 3- and 4-Substituted Derivatives Journal of Medicinal Chemistry ·Michaël Génin,Carolyn Biles,Barb J. Keiser,Susan M. Poppe,Steven Swaney,W. Gary Tarpley,Yoshihiko Yagi,Donna L. Romero	2000	349
6	Synthesis and Structure−Activity Relationships of the (Alkylamino)piperidine-Containing BHAP Class of Non-Nucleoside Reverse Transcriptase Inhibitors: Effect of 3-Alkylpyridine Ring Substitution Journal of Medicinal Chemistry ·Michaël Génin,Toni J. Poel,Paul D. May,Laurice A. Kopta,Yoshihiko Yagi,Robert A. Olmsted,Janice M. Friis,Richard Voorman,Wade J. Adams,Richard C. Thomas,Donna L. Romero	1999	6
7	Pyrimidine Thioethers: A Novel Class of HIV-1 Reverse Transcriptase Inhibitors with Activity Against BHAP-Resistant HIV Journal of Medicinal Chemistry ·Richard A. Nugent,Stephen T. Schlachter,Michael J. Murphy,Gary J. Cleek,Toni J. Poel,Donn G. Wishka,David R. Graber,Yoshihiko Yagi,Barbara J. Keiser,Robert A. Olmsted,Laurie A. Kopta,Steven Swaney,Susan M. Poppe,Joel Morris,W. Gary Tarpley,Richard C. Thomas	1998	56
8	Screening for inhibitors of the HMG-CoA reductase promoter in HepG2 cells: Identification of four non-oxysterol inhibitors Drug Development Research ·Yoshihiko Yagi,Debra J. Bevis,Karen Hart,Gerard F. Hess,Dac M. Dinh,Barbara J. Keiser,Scott D. Larsen,C.H. Spilman	1997	1
9	Targeting Delavirdine/Atevirdine Resistant HIV-1: Identification of (Alkylamino)piperidine-Containing Bis(heteroaryl)piperazines as Broad Spectrum HIV-1 Reverse Transcriptase Inhibitors Journal of Medicinal Chemistry ·Donna L. Romero,Robert A. Olmsted,Toni J. Poel,Raymond A. Morge,Carolyn Biles,Barbara J. Keiser,Laurice A. Kopta,Jan M. Friis,John D. Hosley,Kevin Stefanski,Donn G. Wishka,David Evans,Joel Morris,Randy G. Stehle,Satish Kumar Sharma,Yoshihiko Yagi,Richard Voorman,Wade J. Adams,W. Gary Tarpley,Richard C. Thomas	1996	50
10	Synthesis and Bioactivity of Novel Bis(heteroaryl)piperazine (BHAP) Reverse Transcriptase Inhibitors: Structure−Activity Relationships and Increased Metabolic Stability of Novel Substituted Pyridine Analogs Journal of Medicinal Chemistry ·Michaël Génin,Toni J. Poel,Yoshihiko Yagi,Carolyn Biles,Irene W. Althaus,Barbara J. Keiser,Laurice A. Kopta,Jan M. Friis,Fritz Reusser,Wade J. Adams,Robert A. Olmsted,Richard Voorman,Richard C. Thomas,Donna L. Romero	1996	24
11	Characterization of a Small Plasmid Determining Resistance to Erythromycin, Lincomycin, and Vernamycin B _α in a Strain of Streptococcus sanguis Isolated from Dental Plaque Antimicrobial Agents and Chemotherapy ·Yoshihiko Yagi,Thomas S. McLellan,William A. Frez,Don B. Clewell	1978	35
12	Plasmid-determined tetracycline resistance in Streptococcus faecalis: Tandemly repeated resistance determinants in amplified forms of pAMα1 DNA Journal of Molecular Biology ·Yoshihiko Yagi,Don B. Clewell	1976	52
13	Plasmid-Determined Resistance to Erythromycin: Comparison of Strains of Streptococcus faecalis and Streptococcus pyogenes with Regard to Plasmid Homology and Resistance Inducibility Antimicrobial Agents and Chemotherapy ·Yoshihiko Yagi,Arthur E. Franke,Don B. Clewell	1975	33

About Yoshihiko Yagi

Yoshihiko Yagi is a scholar working on Virology, Infectious Diseases and Molecular Medicine, having authored 13 papers that have together received 681 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), DNA Repair Mechanisms (2 papers), Carcinogens and Genotoxicity Assessment (2 papers), Streptococcal Infections and Treatments (2 papers) and Infective Endocarditis Diagnosis and Management (2 papers). The work is most often cited by research in Organic Chemistry (435 citations), Virology (36 citations) and Infectious Diseases (117 citations). Yoshihiko Yagi has collaborated with scholars based in United States, Japan and Brazil. Frequent co-authors include W. Gary Tarpley, Carolyn Biles, Donna L. Romero, Susan M. Poppe, Steven Swaney, Don B. Clewell, Michaël Génin, Arthur E. Franke, Richard C. Thomas and Toni J. Poel. Their work appears in journals such as Journal of Molecular Biology, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact